Managers

Alta Partners gathers $130 mln for healthcare fund

Alta Partners, a healthcare-focused venture firm, has raised $130 million for its new fund. Alta Partners NextGen Fund I LP will focus on developing novel biotherapeutics and technology-enabled healthcare services.

Collab Currency targets $100 mln for venture fund

Collab+Currency is raising a venture fund targeted at $100 million, according to a regulatory filing. The New York-based firm is led by Craig Shapiro, founder and managing partner of Collaborative Fund.

Foundry.ai raises $67.7 mln venture-capital fund

Foundry.ai has raised a $67.7 million maiden venture-capital fund, according to a filing with the SEC.

Domo headed toward down-round IPO

Eleven Ventures seeks $20 mln

Palo Alto, California-based Eleven Ventures is seeking to raise $20 million, according to a regulatory filing. the early-stage firm, launched last year by serial entrepreneurs Michael Howse and Greg Ballard, seeks to invest in consumer and enabling tech startups in VR/AR, digital gaming and e-sports.

Romulus Capital collects over $83 mln for third fund

Romulus Capital has raised over $83 million for its third fund, according to an amended SEC filing. No target was listed on the document. Boston-based Romulus Capital is an early-stage venture firm focused on tech companies.

Juvenescence lands $50 mln Series A

Juvenescence, a developer of therapies for ageing and age-related diseases, has raised $50 million in Series A funding. The investors in this round were not named.

KRY pockets $66 mln Series B in Index Ventures-led round

KRY, a Swedish digital healthcare provider that lets the user see a healthcare professional within 15 minutes via a smartphone or tablet, has raised $66 million in Series B funding. Index Ventures led the round with participation from previous backers Accel, Creandum and Project A.

Pharmapacks fetches $32.5 mln

Pharmapacks, an ecommerce company that sells health and beauty items, has raised $32.5 million in funding. RB led the round with participation from McKesson Ventures, Sealed Air and The Emerson Group.

Vergent Bioscience nabs $8.7 mln Series A

Minneapolis-based Vergent Bioscience, a cancer-focused biotechnology company, has raised $8.7 million in Series A financing. Spring Mountain Capital led the round.